The preliminary study of renal arteriovenous transit time in evaluating renal function in patients before liver transplantation

SU Yijin,DU Lianfang,LI Fan,XU Qi
DOI: https://doi.org/10.16245/j.cnki.issn1008-6978.2008.04.029
2008-01-01
Abstract:Objective To study the value of the renal arteriovenous transit time(RAVTT) in evaluating renal function with contrast-enhanced ultrasound(CEUS) in patients with hepatic cirrhosis before liver transplantation.Methods One hundred and two patients with hepatic cirrhosis before liver transplantation were examined by CEUS,including 36 compensated cirrhosis patients,43 decompensated cirrhosis and 23 patients with hepatorenal syndrome(HRS).Forty-five health adults were in control group.After injection of SonoVue,the arrival time(AT) of the contrast agents echoes in the renal portal artery and renal portal vein was analyzed.Results There was no significant difference of RAAT,RVAT and RAVTT between control group and compensated cirrhosis group(P>0.05).However,RAAT,RVAT and RAVTT of decompensated cirrhosis group were longer than that of the control group and compensated cirrhosis group(P<0.05),RAAT,RVAT and RAVTT of hepatorenal syndrome(HRS) group were obviously longer than that of other three groups(P<0.05).Conclusion Renal arteriovenous transit time of CEUS could be used as a reference index in evaluating renal function before liver transplantation.
What problem does this paper attempt to address?